- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 04.08. | RespireRx Pharmaceuticals Inc. CFO and CEO Issue Letter to Stockholders, Stakeholders, Strategic and Potential Strategic Partners and Other Interested Parties | 268 | GlobeNewswire (Europe) | Glen Rock, N.J., Aug. 04, 2026 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. ("RespireRx" or the "Company"), a leader in the discovery and development of innovative and revolutionary treatments... ► Artikel lesen | |
| RESPIRERX Aktie jetzt für 0€ handeln | |||||
| 20.11.25 | RespireRx Pharmaceuticals Inc. CFO and CEO Issue Letter to Stockholders, Stakeholders, Strategic and Potential Strategic Partners and Other Interested Parties | 268 | GlobeNewswire (Europe) |
Glen Rock, N.J., Nov. 20, 2025 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (RespireRx or the Company), and its subsidiaries, EndeavourRx LLC (EndeavourRx) and ResolutionRx Ltd (ResolutionRx)... ► Artikel lesen | |
| 19.11.25 | RespireRx Pharmaceuticals Inc. Announces NIH/NINDS Grant Award and Amended and Restated Patent License Agreement | 329 | GlobeNewswire (Europe) | Glen Rock, N.J., Nov. 19, 2025 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. ("RespireRx" or the "Company"), a leader in the discovery and development of innovative and revolutionary treatments... ► Artikel lesen | |
| 18.11.25 | RespireRx Pharmaceuticals Inc. Announces SEC Order Making Findings and Revoking Registration of Securities and Future Plans with respect to its Common Stock | 530 | GlobeNewswire (Europe) | Glen Rock, N.J., Nov. 18, 2025 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. ("RespireRx", "RSPI", "Respondent" or the "Company"), a leader in the discovery and development of innovative and... ► Artikel lesen |
4 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| DIGICANN VENTURES | 0,006 | 0,00 % | XFRA VY3: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| IONIS PHARMACEUTICALS | 39,830 | +1,04 % | DelveInsight Business Research, LLP: Severe Hypertriglyceridemia Market Set for Growth During the Forecast Period (2026-2036) Following Approval of Ionis' TRYNGOLZA and Emergence of Novel Therapies | DelveInsight | Severe Hypertriglyceridemia Market Set for Growth During the Forecast Period (2026-2036) Following Approval of Ionis' TRYNGOLZA and Emergence of Novel Therapies | DelveInsight
The severe hypertriglyceridemia... ► Artikel lesen | |
| SINOPHARM | 1,742 | -1,69 % | SINOPHARM (01099): ANNOUNCEMENT PRELIMINARY FINANCIAL DATA OF SINOPHARM ACCORD FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2026 | ||
| CSPC PHARMA | 0,922 | -7,09 % | Dividendenbekanntmachungen (20.10.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AMERICAN TOWER CORPORATION US03027X1000 1,79 USD EUR ANHUI CONCH CEMENT CO LTD ADR US0352431045 0,096 USD EUR ANTIN INFRASTRUCTURE... ► Artikel lesen | |
| ORAMED PHARMACEUTICALS | 3,560 | 0,00 % | Oramed Pharmaceuticals Inc.: Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic Portfolio Appreciation, and a Strengthened Balance Sheet | Significant Appreciation in Alpha Tau (NASDAQ: DRTS) Position (up ~$128 Million)
Scilex (NASDAQ: SCLX) Loan Substantially Repaid
Total Cash and Assets Build... ► Artikel lesen | |
| ADASTRA | 0,142 | -100,00 % | CSE Bulletin: Suspensions - Adastra Holdings Ltd., CAT Strategic Metals Corporation, Greenrise Global Brands Inc., StickIt Technologies Inc. | Le 12 mai/May 2026
Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as defined in National Instrument 23-101... ► Artikel lesen | |
| SELLAS LIFE SCIENCES | 10,650 | -1,84 % | XETR NEW INSTRUMENTS AVAILABLE ON XETRA - 19.10.2026 | Folgende Wertpapiere werden in den Handel an der Frankfurter Wertpapierbörse (FWB) aufgenommen.
1. US88025U1097 10X GENOMICS INC
2. NL0000852564 AALBERTS NV
3. SE0016589188 ELECTROLUX AB
4. SE0000115446... ► Artikel lesen | |
| MADRIGAL PHARMACEUTICALS | 421,90 | +3,46 % | Madrigal Pharmaceuticals, Inc.: Madrigal Pharmaceuticals Reports Second-Quarter 2026 Financial Results and Provides Corporate Updates | Second-quarter 2026 Rezdiffra- (resmetirom) net sales of $364.3 million, representing year-over-year growth of 71% As of June 30, 2026, more than 49,000 patients on Rezdiffra, more than doubling... ► Artikel lesen | |
| ACADIA PHARMACEUTICALS | 18,030 | +0,25 % | Acadia Pharmaceuticals Inc.: Europäische Kommission erteilt Zulassung für DAYBU (Trofinetid) als erste und einzige Therapie für neurobehaviorale Symptome des Rett-Syndroms in der Europäischen Union | Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) hat heute bekannt gegeben, dass die Europäische Kommission (EK) die Marktzulassung für DAYBU (Trofinetid) zur Behandlung neurobehavioraler Symptome des Rett-Syndroms... ► Artikel lesen | |
| CATALYST PHARMACEUTICALS | 27,300 | +2,63 % | Angelini Pharma Completes Acquisition of Catalyst Pharmaceuticals | The Italian pharma company grows its presence in the U.S. market and strengthens its global leadership in Brain Health and Rare DiseasesCompletion of the transaction gives Angelini Pharma ownership... ► Artikel lesen | |
| METRIOPHARM | - | - | Press Release: MetrioPharm AG: Prof. Dr. med. Jürgen Braun Appointed as New Member of the Scientific Advisory Board | Press Release: MetrioPharm AG: Prof. Dr. med. Jürgen Braun Appointed as New Member of the Scientific Advisory Board
-- Prof. Dr. med. Jürgen Braun joins the Scientific Advisory Board of
MetrioPharm... ► Artikel lesen | |
| MOLECULE HOLDINGS | 0,001 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.10.2026 -1- | The following instruments on Boerse Frankfurt do have their last trading day on 02.10.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.10.2026ISIN NameAGP8696W1045 SINOVAC... ► Artikel lesen | |
| BAYER | 44,630 | +2,64 % | Bayer nach 15 % Kursverlust Stabilisierung an der 200-Tage-Linie | Nach dem Rückgang von mehr als 15 % hat sich die Bayer-Aktie im Bereich der 200-Tage-Linie stabilisiert. Gleichzeitig bleibt der Bruch der früheren Unterstützung und die weiterhin neutrale Korrekturphase... ► Artikel lesen | |
| MERCK KGAA | 142,25 | -2,83 % | ROUNDUP/Aktien New York Schluss: Nasdaq etwas erholt - Dow fast unverändert | NEW YORK (dpa-AFX) - Nach der jüngsten Talfahrt hat die technologielastige US-Börse Nasdaq am Montag einen Erholungsversuch gestartet. Der Nasdaq-Auswahlindex 100 legte um 1,17 Prozent auf 29.529,34... ► Artikel lesen | |
| TEVA PHARMACEUTICAL INDUSTRIES | 40,590 | -0,06 % | Teva/Sanofi: Duvakitug Maintains Meaningful Efficacy Improvements In Long-term Extension Study | PETAH TIKVA (dpa-AFX) - Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries (TEVA), and Sanofi announced new positive data from the RELIEVE UCCD phase 2b long-term extension... ► Artikel lesen |
Das Unternehmen RESPIRERX PHARMACEUTICALS INC kann der Branche Pharma zugeordnet werden.
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu RESPIRERX PHARMACEUTICALS INC finden Sie auf Wallstreet Online.